lactic acid has been researched along with Intestinal Neoplasms in 4 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Intestinal Neoplasms: Tumors or cancer of the INTESTINES.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Similarly, for pharmacokinetic (PK) studies, higher oral bioavailability was observed from DTX-CS-PLGA-NPs (5." | 1.48 | Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer. ( Ahmad, FJ; Ahmad, N; Ahmad, R; Alam, MA; Naqvi, AA, 2018) |
| "Especially for the treatment of intestinal cancer it offers the possibility of a local treatment with a reduced likelihood for adverse drug reactions." | 1.48 | Mucus-penetrating nanoparticles: Promising drug delivery systems for the photodynamic therapy of intestinal cancer. ( Anderski, J; Langer, K; Mahlert, L; Mulac, D, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, N | 1 |
| Alam, MA | 1 |
| Ahmad, R | 1 |
| Naqvi, AA | 1 |
| Ahmad, FJ | 1 |
| Anderski, J | 1 |
| Mahlert, L | 1 |
| Mulac, D | 1 |
| Langer, K | 1 |
| Allen, E | 1 |
| Miéville, P | 1 |
| Warren, CM | 1 |
| Saghafinia, S | 1 |
| Li, L | 1 |
| Peng, MW | 1 |
| Hanahan, D | 1 |
| GJESSING, LR | 1 |
4 other studies available for lactic acid and Intestinal Neoplasms
| Article | Year |
|---|---|
Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Topics: A549 Cells; Animals; Biological Transport; Docetaxel; Drug Carriers; Drug Liberation; Humans; Intest | 2018 |
Mucus-penetrating nanoparticles: Promising drug delivery systems for the photodynamic therapy of intestinal cancer.
Topics: Administration, Oral; Caco-2 Cells; Chitosan; Drug Delivery Systems; Humans; Intestinal Mucosa; Inte | 2018 |
Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling.
Topics: Angiogenesis Inhibitors; Animals; Axitinib; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expres | 2016 |
STUDIES OF FUNCTIONAL NEURAL TUMORS. V. URINARY EXCRETION OF 3-METHOXY-4HYDROXYPHENYL-LACTIC ACID.
Topics: Acetates; Adrenal Gland Neoplasms; Butyrates; Carcinoid Tumor; Child; Chromatography; Dihydroxypheny | 1963 |